Unfortunately, advanced-stage, castration-resistant PCa cells have been identified to produce testosterone intracellularly [208] and develop resistance to ADT via other mechanisms such as gene or enhancer amplification, receptor mutations, receptor variants, and coactivator overexpression of the androgen receptors (AR) [21]. The gene discussed is AR; the disease is posterior cortical atrophy.